Roy Moncayo

Prof. Roy Moncayo

1. Department of Nuclear Medicine of the Medical, University of Innsbruck, Innsbruck, Austria
+1
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2010 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
EBEmilio Bombardieri
Emilio Bombardieri
FGFrancesco Giammarile
Francesco Giammarile
CACumali Aktolun
Cumali Aktolun
RBRichard P. Baum
Richard P. Baum
ADAngelika Bischof Delaloye
Angelika Bischof Delaloye
ACArturo Chiti
Arturo Chiti
The aim of this document is to provide general information about mIBG scintigraphy in cancer patients. The guidelines describe the mIBG scintigraphy protocol currently used in clinical routine, but do not include all existing procedures for neuroendocrine tumours. The guidelines should therefore not be taken as exclusive of other nuclear medicine modalities that can be used to obtain comparable results. It is important to remember that the resources and facilities available for patient care may vary from one country to another and from one medical institution to another. The present guidelines have been prepared for nuclear medicine physicians and intend to offer assistance in optimizing the diagnostic information that can currently be obtained from mIBG scintigraphy. The corresponding guidelines of the Society of Nuclear Medicine (SNM) and the Dosimetry, Therapy and Paediatric Committee of the EANM have been taken into consideration, and partially integrated into this text. The same has been done with the most relevant literature on this topic, and the final result has been discussed within a group of distinguished experts.

1 April 2002 in Seminars in Nuclear Medicine
Verified
Journal Article
Closed access
IVIrene Virgolini
Irene Virgolini
KBKeith Britton
Keith Britton
JBJohn Buscombe
John Buscombe
Roy MoncayoRoy Moncayo
Roy Moncayo
GPGiovanni Paganelli
Giovanni Paganelli
PRPietro Riva
Pietro Riva

27 November 2008 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
KKKlaus Kapelari
Klaus Kapelari
CKChristine Kirchlechner
Christine Kirchlechner
WHWolfgang Högler
Wolfgang Högler
KSKatharina Schweitzer
Katharina Schweitzer
IVIrene Johanna Virgolini
Irene Johanna Virgolini
Roy MoncayoRoy Moncayo
Roy Moncayo
Age- and sex-specific reference intervals are an important prerequisite for interpreting thyroid hormone measurements in children. However, only few studies have reported age- and sex-specific pediatric reference values for TSHbasal (TSH), free T3 (fT3), and free T4 (fT4) so far. Reference intervals are known to be method- and population-dependent. The aim of our study was to establish reference intervals for serum TSH, fT3, and fT4 from birth to 18 years and to assess sex differences.

17 June 2000 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
Clemens DecristoforoClemens Decristoforo
Clemens Decristoforo
SMStephen J. Mather
Stephen J. Mather
WCWitold Cholewinski
Witold Cholewinski
EDEveline Donnemiller
Eveline Donnemiller
GRGeorg Riccabona
Georg Riccabona
Roy MoncayoRoy Moncayo
Roy Moncayo

22 January 2009 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
PMPeter Malik
Peter Malik
RGRudolf W Gasser
Rudolf W Gasser
GKGeorg Kemmler
Georg Kemmler
Roy MoncayoRoy Moncayo
Roy Moncayo
GFGerd Finkenstedt
Gerd Finkenstedt
WFW. Wolfgang Fleischhacker
W. Wolfgang Fleischhacker

1 December 1989 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
HMH Moncayo
H Moncayo
Roy MoncayoRoy Moncayo
Roy Moncayo
RBR Benz
R Benz
AWA Wolf
A Wolf
CLC Lauritzen
C Lauritzen
We developed an ELISA system for the detection of human anti-ovarian antibodies. Bovine corpora lutea were extracted in PBS (pH 7.2) and fractionated by ultracentrifugation. Both the soluble fraction obtained after 80,000 g (S80) and the Triton-extracted membrane fraction (ST288) were used as antigens. Additionally, the luteinizing hormone (LH)/human chorionic gonadotropin (hCG) receptor was isolated by affinity chromatography (wheat germ agglutinin and LH-Sepharose) and also used as an antigen. In 7 of 14 patients with primary sterility and endometriosis a positive reaction was observed. Similarly, 6 of 16 patients with secondary sterility and endometriosis were also positive. Patients being stimulated for in vitro fertilization and presenting either primary or secondary sterility were positive in 5 of 22 and 6 of 16 cases, respectively. In the S80 test 41 of 60 sera presented IgG2 antibodies, whereas in the ST288 test 38 of 60 belonged to the IgG1 subclass. Kappa and lambda chains were equally distributed. Some patients could recognize the unoccupied LH/hCG receptor as an antigen, while others recognized only the complex formed by the hormone plus the hormone receptor. The S80 and ST288 antigens were isolated by affinity chromatography. Gel permeation of the purified antigens revealed in each case the presence of an antigen complex. The apparent molecular weight was between 2,000 and 36,000 D. Cross-reactivity studies using affinity-purified antibodies demonstrated an antigenic relationship of the membrane, soluble, and extractable fractions. NAc-(beta-1----4)-D-glucosaminide and -D-galactopyranoside were the main terminal glycosides.